2.04 USD
↘ 0.03 (1.45%)AT CLOSE (03:59 PM EDT)
Acumen Pharmaceuticals, Inc. Common Stock
ABOSNASDAQ • USD
2.04
↗ 0.00 (0.10%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
2.04
↗ 0.00 (0.10%)
Market: CLOSED
Shares of Acumen Pharmaceuticals, Inc. Common Stock (ABOS) are trading at $2.04. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest ABOS is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 2, 2026.
Open?$2.10
High?$2.10
Low?$2.02
Prev. Close?$2.07
Volume?580.5K
Avg. Volume?478.3K
VWAP?$2.04
Rel. Volume?1.21x
Bid / Ask
Bid?$1.76 × 100
Ask?$2.46 × 100
Spread?$0.70
Midpoint?$2.11
Valuation & Ratios
Market Cap?147.5M
Shares Out?72.3M
Float?37.4M
Float %?51.8%
P/E Ratio?N/A
P/B Ratio?2.58
EPS?-$1.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
Employees
61
Market Cap
147.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-07-01
Address
1210-1220 WASHINGTON STREET
NEWTON, MA 02465
Phone: 617-344-4190
NEWTON, MA 02465
Phone: 617-344-4190
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?59
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.81Distress
Confidence?44%Low
Short InterestHigh
Short % of Float?7.49%Elevated
Short Interest?2.8M
Days to Cover?8.2
Free Float37.4M
Avg Daily Volume343.8K
Settlement Date2026-09-15
Financial Health
Current Ratio?2.47Strong
Quick Ratio?2.47Strong
Cash Ratio?1.27Strong
Debt/Equity?0.55Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.58CHEAP▾
Peers100
S&P63
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-183.4%WEAK▾
S&P3
ROA?-90.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-91788000
Enterprise Value?$119.7M
Fundamentals ratios updated end of day